Tenaya Therapeutics Inc (TNYA)
4.295
+0.10
(+2.26%)
USD |
NASDAQ |
May 13, 16:00
4.295
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Total Assets (Quarterly): 170.52M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 170.52M |
| September 30, 2023 | 193.40M |
| June 30, 2023 | 220.75M |
| March 31, 2023 | 245.34M |
| December 31, 2022 | 278.94M |
| September 30, 2022 | 226.31M |
| June 30, 2022 | 255.93M |
| Date | Value |
|---|---|
| March 31, 2022 | 281.50M |
| December 31, 2021 | 314.19M |
| September 30, 2021 | 331.79M |
| June 30, 2021 | 156.90M |
| March 31, 2021 | 159.76M |
| December 31, 2020 | 148.16M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
148.16M
Minimum
Dec 2020
331.79M
Maximum
Sep 2021
229.50M
Average
226.31M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 99.03B |
| Solid Biosciences Inc | 164.94M |
| Dyne Therapeutics Inc | 522.28M |
| Sana Biotechnology Inc | 681.38M |
| Prime Medicine Inc | 193.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.09M |
| Shareholders Equity (Quarterly) | 139.42M |